Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

st. mary's medical park pharmacy - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome ( see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydro

Australija - engleski - Department of Health (Therapeutic Goods Administration)

life systems medical pty ltd - 36551 - patient monitoring system module, blood pressure, noninvasive - the finapres nova is a standalone device intended for desktop use. measurements are to be performed under uninterrupted patient surveillance of the operator. the finapres nova is used in a professional medical environment (i.e. hospitals, clinics and research institutions etc.). the finapres nova is suitable for use in an operating room in the non-sterile zone.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

life systems medical pty ltd - 46428 - electrical catheter connection cable, reusable - the intended use of the bmc connector cable is to connect the bmc rf puncture generator to baylis medical puncture catheters.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

life systems medical pty ltd - 35156 - radio-frequency ablation system generator - the baylis medical puncture generator is intended to create an atrial septal defect in the heart.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

life systems medical pty ltd - 65159 - electrical-only medical device connection adaptor, single-use - the sterile adapter allows connecting equipment with 2mm socket to pacing leads. the adapters can also be fixed to the equipment by means of cyanacrylic adhesive, supplied separately.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - nitrous oxide, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - indications: 1. general anaesthesia: when an inhalation anaesthetic is required, the administration is usually accompanied by simultaneous administration of a volatile agent such as halothane, ethrane, etc. 2. analgesia with oxygen: - relief from severe pain, usually in emergency situations, by inhalation with oxygen. - useful also in short-term procedures which inevitably involve pain, such as wound and burn dressing, wound debridement and suturing. administration with oxygen. - in dental work to provide short-term analgesia for tooth extraction and other brief procedures. administration with oxygen. 3. others: - occasionally as an insufflating agent in laparoscopy. - in cryosurgery as a refrigerant.

Irska - engleski - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - amitriptyline hydrochloride - film-coated tablet - 25 milligram(s) - non-selective monoamine reuptake inhibitors; amitriptyline

Australija - engleski - Department of Health (Therapeutic Goods Administration)

supagas pty ltd - air, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - air for medical use. for normal respiration. in anaesthetic equipment as a carrier gas during surgery. for nebulisation of inhaled drugs when oxygen supplementation is not required.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

a-s medication solutions - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see  warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see  warnings  and  dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

unit dose services - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period